Banner
Pilot Study: Fibromyalgia Fatigue Improved By TENS Therapy

Fibromyalgia is the term for a poorly-understood condition where people experience pain and fatigue...

High Meat Consumption Linked To Lower Dementia Risk

Older people who eat large amounts of meat have a lower risk of dementia and cognitive decline...

Long Before The Inca Colonized Peru, Natives Had A Thriving Trade Network

A new DNA analysis reveals that long before the Incan Empire took over Peru, animals were...

Mesolithic People Had Meals With More Tradition Than You Thought

The common imagery of prehistoric people is either rooting through dirt for grubs and picking berries...

User picture.
News StaffRSS Feed of this column.

News Releases From All Over The World, Right To You... Read More »

Blogroll

Scientists at the University of Glasgow have made a second significant breakthrough in the treatment of chronic myeloid leukaemia – using precision medicine to kill more than 90% of chronic myeloid leukaemia (CML) stem cells. The results are published today in the high impact journal Cancer Discovery.

CML is a rare form of blood cancer. An individual gets CML when normal blood stem cells are turned into leukaemic stem cells, or CML stem cells. These CML stem cells then produce large numbers of leukaemic cells which, if left untreated, is fatal.

With one billion stars mapped in a thousand days, European researchers have shown that they are not afraid to tackle the most daunting tasks. The work was carried out by 450 researchers from 25 European countries, including around a hundred scientists from France, mainly at the CNRS, Observatoire de Paris and Observatoire de la Côte d’Azur[1], with major participation by the French space agency CNES. Using the Gaia spacecraft, launched on 19 December 2013, scientists have catalogued the position of 1.15 billion stars, and in addition measured the velocity and distance of two million of them relative to the Sun. ESA[2] and the European consortium DPAC[3] are releasing the mission's first findings on September 14.

The following factors facilitate the formation of putatively toxic structures in the neuronal nuclei of Alzheimer’s patients.

Spherical structures in the nucleus of nerve cells, so-called nuclear spheres, are suspected to trigger Alzheimer’s disease. A team headed by Dr Thorsten Müller from the research group Cell Signaling in Neurodegeneration has for the very first time demonstrated the presence of the presumably toxic protein aggregates in the human brain. The researchers from Ruhr-Universität Bochum have published their article in the journal Neurobiology of Aging.

Number of nuclear spheres higher in Alzheimer’s patients

Visualization was enabled by designing a new artificial magnetic material. The finding means remarkable possibilities to materials research.

Researchers at Aalto University and Lawrence Berkeley National Laboratory have demonstrated that polaron formation also occurs in a system of magnetic charges, and not just in a system of electric charges. Being able to control the transport properties of such charges could enable new devices based on magnetic rather than electric charges, for example computer memories.

The sense of touch may play a more crucial role in autism spectrum disorder (ASD) than previously assumed. The main findings of the doctoral research of Eliane Deschrijver, which are now published, show that individuals with ASD may have difficulties to determine which tactile sensations belong to the action of someone else.

ASD: social problems and sensory sensitivities

Many individuals with ASD are over- or undersensitive to sensory information. Some feel overwhelmed by busy environments such as supermarkets, others are less sensitive to pain, or dislike being touched.

  • Alzheimer's may also affect language, behavior or spatial judgment

  • These patients often are not given an opportunity to be in Alzheimer's clinical trials
  • Amyloid PET scan offers way to identify underlying disease and have more inclusive clinical trials

    CHICAGO --- Relying on clinical symptoms of memory loss to diagnose Alzheimer's disease may miss other forms of dementia caused by Alzheimer's that don't initially affect memory, reports a new Northwestern Medicine study.